Stock Analysis
Lemonade, Inc. (LMND)
NYSE: LMND · Insurance / Financial Technology
Updated
Rated Watchlist, with a fair value of $48.94 against a last close of $43.86 (+11.6% implied upside). Lemonade reached the $44 watch price, but a fair value rebuilt on year-end 2027 in-force premium puts the base case at $48.94, only 11.6% away, so Watchlist holds with the watch price reset to $39 and a clean Q3 on 4 November as the other route to a Buy up to about $45.
- Verdict
- Watchlist
- Fair Value
- $48.94
- Investment Score
- 55.4/100prev 61.3
Technical read (chart only): Confirms as of The shares were in a breakdown below every major average at a new 60-session closing low; the signal to watch was a reclaim of the 50-day average near $49.52 followed by a higher low.The Watchlist verdict comes from the fundamentals alone. The technical read looks only at the price chart. It does not change the verdict or the score and only guides entry timing.
Investment Scorecard
Composite score 55.4/100 (previous 61.3). Every factor is scored out of 10, ten always being the best outcome, including for risk.
| Factor | Score | Weight | Change | Basis |
|---|---|---|---|---|
| Business Quality | 6/10 | 16% | unchanged | Low-cost claims handling and a young customer base; underwriting still unproven at scale. |
| Financial Strength | 6/10 | 16% | unchanged | About $1.2bn of cash and investments and near break-even operating cash flow, but losses continue. |
| Competitive Advantage | 5/10 | 16% | -1 vs last report | Car, the line the case needs, is where incumbents are strongest; the Tesla update is unsized. |
| Management | 6/10 | 10% | -1 vs last report | Guidance met, but growth spend is keeping pace with premium and the CFO changes in January. |
| Growth Potential | 7/10 | 16% | -1 vs last report | Premium growth of 32% is strong, but it is being bought at almost the same rate. |
| Valuation | 5/10 | 16% | -1 vs last report | 11.6% to the $48.94 base case and 38% to the bear case. |
| Risk (10 = lowest risk) | 3/10 | 10% | -1 vs last report | A binary Q4 test, an open hurricane season and high rate sensitivity. |
Recent Developments
| Date | Development | Impact |
|---|---|---|
| Investor Day Scheduled for 17 November 2026 in New York, per the company's investor page. No targets announced yet. Reading: Could set longer-range profit targets that the valuation currently has to assume. | Medium | |
| Q3 2026 results Expected 4 November; not yet announced by the company. Q3 guide: in-force premium $1,537-1,540m, adjusted EBITDA -$23m to -$20m. Management expects positive Q4 adjusted EBITDA, about $8m implied. Reading: The last read before the Q4 inflection and the main route back to a Buy. | Medium | |
| Autonomous Car adds Tesla FSD v14 Lite (HW3) Company release: HW3 Teslas on FSD (Supervised) v14 Lite get 30% off miles driven with FSD engaged; HW4 on v14.2 or newer keeps 50%. Arizona, Colorado and Tennessee. No customer or premium figures. Reading: Supports the car strategy by widening the eligible fleet, but it is unsized and moved no score. | Medium | |
| Hurricane season The Atlantic ended September without a hurricane for the first time in 32 years; the season runs to 30 November. Reading: Lowers the risk of a catastrophe-driven Q3 miss but does not settle Q4. | Medium | |
| CFO succession Tim Bixby moves to the board on 1 January 2027; Nick Stead, SVP Finance, becomes CFO (Form 8-K, 29 July 2026). Reading: Lands in the first quarters of profitability; no execution signal either way so far. | Low | |
| Renters launched in Alaska and Hawaii Alaska on 29 September and Hawaii on 6 October continue the state-by-state renters rollout. Reading: Adds reach on the cheapest acquisition line; no thesis effect. | Low |
Key Risks
| Risk | Probability | Severity | Comment |
|---|---|---|---|
| Q4 inflection deferred | Medium | High | The single event the case rests on; a slip leaves a loss-making insurer with no near-term earnings. |
| Catastrophe losses | Low-Medium | High | Quiet season so far, but it runs to 30 November and home and car books concentrate exposure. |
| Discount-rate sensitivity | High | Medium | Priced off long yields near their highest since 2002. |
| Claims-cost inflation | Medium | Medium | Vet costs are rising across pet insurance; repair and shelter costs feed home and car. |
| Growth spend outpacing premium | Medium | Medium | Growth spend rose 30% in Q2 against 32% premium growth; financing is costly. |
| Management transition | Low | Medium | New CFO from January, in the first quarters of profitability. |
Scenario Analysis
| Case | Probability | Fair Value | Outlook |
|---|---|---|---|
| Bull | 25% | $69.10 | Q4 turns positive on schedule and 2027 is the first profitable year; in-force premium grows 30% to about $2.13bn by end-2027; 2.6x. |
| Base | 50% | $48.94 | Guidance met without an upgrade; Q4 turns positive and leverage arrives gradually; in-force premium grows 26% to about $2.06bn; 1.9x. |
| Bear | 25% | $26.99 | Catastrophe losses or growth spend push the inflection into 2028; premium growth slows to 20% (about $1.96bn); 1.1x. |
The Case
Would an investor buy Lemonade at $43.86? Not yet. Premium is growing above 30% and the first positive adjusted EBITDA quarter is guided for Q4, but the company has no profits, growth is being bought at almost the rate it arrives, and the shares are priced off long yields near two-decade highs. With 11.6% to the $48.94 base case and the bear case 38% below, the reward does not pay for the risk. A price near $39, or a Q3 report on 4 November that keeps the Q4 guidance intact, would change the answer.
Archived Reports
Beating The Bull keeps every past version of this report on file. Verdicts and numbers reflect what was known when each one was published.
Informational use only. Not financial advice.